| 1 |
Acazicolcept
💬 | 1件: Acazicolcept Acazicolcept (Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways) | 1件: Acazicolcept Acazicolcept | 2件: CD28 CD28,
ICOS 💬
| 14件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 49 49 💬
|
| 2 |
Efavaleukin alfa
💬 | 1件: Efavaleukin alfa Efavaleukin alfa (Fc il-2 mutein fusion protein) | 1件: EFAVALEUKIN ALFA EFAVALEUKIN ALFA | - | - | 2件: 49 49, 97 💬
|
| 3 |
Efzofitimod
💬 | 1件: Efzofitimod Efzofitimod (Human IgG1Fc- iMod domain of human HARS fusion protein) | 1件: Efzofitimod Efzofitimod | 2件: HARS1 HARS1,
HARS2 💬
| 1件: Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis 💬 | 2件: 51 51, 84 💬
|
| 4 |
Tralesinidase alfa
💬 | 1件: Tralesinidase alfa Tralesinidase alfa (NAGLU-IGF2 fusion protein) | 2件: RHNAGLU-IGF2 RHNAGLU-IGF2; Tralesinidase alfa | 2件: IGF2 IGF2,
NAGLU 💬
| 9件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Hepatocellular carcinoma, Hormone signaling, Lysosome biogenesis, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Ras signaling pathway 💬 | 1件: 19 19 💬
|
